ММВБ 3 125 0,3%  Nasdaq 9 751 -0,7%  Биткойн 9 715 1,0%  USD/RUB 64,1030 -0,1% 
РТС 1 536 -0,4%  S&P500 3 373 -0,4%  Нефть 58,9 -0,4%  EUR/RUB 69,2450 0,1% 
Dow 29 220 -0,4%  FTSE100 7 437 -0,3%  EUR/USD 1,0793 0,1% 

Курс акций Amgen [ISIN: US0311621009]

купить
продать

Amgen Inc. - Профиль

Amgen Inc. – глобальная биотехнологическая компания, разрабатывающая лекарственные препараты для лечения рака, ревматоидного артрита и других тяжелых заболеваний. Около 60% выручки 2012 года ($16,6 млрд) приходится на три основных препарата компании – Neulasta и Neupogen, позволяющих бороться с инфекциями при лечении рака, и Enbrel, предназначенного для лечения различных видов артритов.

Акционеры

Название Доля (%)
Freefloat99,79
Vanguard Group, Inc. (Subfiler)7,92
The Vanguard Group, Inc.7,66
Capital Research & Management Co. (Global Investors)5,60
State Street Corp.4,33
Fidelity Management & Research Co. LLC3,73
PRIMECAP Management Co.3,03
Vanguard Total Stock Market Index Fund2,84
BlackRock Fund Advisors2,70
BlackRock Institutional Trust Co. NA2,50
Vanguard 500 Index Fund2,00
Vanguard Primecap Fund1,73
Geode Capital Management LLC1,66
Northern Trust Corp.1,45
Capital Income Builder1,37

Адрес

One Amgen Center Drive, 91320-1799 Thousand Oaks
а/я:
Телефон: +1 (805) 447-1000
Факс: +1 (805) 447-1010
Вэб: http://www.amgen.com

Менеджмент

Robert A. Bradway
Chairman & Chief Executive Officer
Cynthia M. Patton
Chief Compliance Officer & Senior Vice President
Peter H. Griffith
Chief Financial Officer
Mike Zahigian
Chief Information Officer & Senior Vice President
Darryl Sleep
Chief Medical Officer & Senior VP-Global Medical
Brian J. Druker
Director
Murdo J. Gordon
EVP-Global Commercial Operations
Janet Cheetham
Executive Director-Process Development
Esteban Santos
Executive Vice President-Operations
David M. Reese
Executive Vice President-Research & Development
Tyler Jacks
Independent Director
Wanda M. Austin
Independent Director
Ronald D. Sugar
Independent Director
Rebecca M. Henderson
Independent Director
Ellen Jamison Kullman
Independent Director
Greg C. Garland
Independent Director
Robert Sanders Williams
Independent Director
Charles M. Holley
Independent Director
Fred Hassan
Independent Director
Robert A. Eckert
Lead Independent Director
Judy L. Brown
SVP-Global Business Services & Finance
Jonathan P. Graham
Secretary, Executive VP & General Counsel
Steven K. Galson
Senior VP-Global Regulatory Affairs & Safety
Mike Nohaile
Senior VP-Strategy, Commercialization & Innovation
Corinne Le Goff
Senior Vice President
David A. Piacquad
Senior Vice President-Business Development
Raymond C. Jordan
Senior Vice President-Corporate Affairs
Elliott M. Levy
Senior Vice President-Global Development
Lori A. Johnston
Senior Vice President-Human Resources
Paul R. Eisenberg
Senior Vice President-U.S. Medical
Victoria H. Blatter
Senior Vice President-US Government Affairs
Gregory Friberg
Vice President-Global Development
Arvind K. Sood
Vice President-Investor Relations

Добавить или редактировать инструмент